Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Postoperative Nausea and Vomiting
NCT02286752Phase 4Completed
- Sponsor
- Ordu University
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in postoperative nausea and vomiting (PONV), sponsored by Ordu University. Started Jun 2014; status: completed.
02
Drugs
Sugammadex
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02286752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286752.